Dendritic Cell Count in the Graft Predicts Relapse in Patients with Hematologic Malignancies Undergoing an HLA-Matched Related Allogeneic Peripheral Blood Stem Cell Transplant

Biology of Blood and Marrow Transplantation

Volumn 16, Issue 6, 2010, Pages 854-860

  Rajasekar, Reena ^a   Lakshmi, Kavitha M ^a   George, Biju ^a   Viswabandya, Auro ^a   Thirugnanam, Rajasekar ^a   Abraham, Aby ^a   Chandy, Mammen ^a   Srivastava, Alok ^a   Mathews, Vikram ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

Dendritic cells; Graft composition; Immune reconstitution; Relapse risk

Indexed keywords

ADOLESCENT; ADULT; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; ARTICLE; CANCER RELAPSE; CANCER SURVIVAL; CELL COUNT; CHILD; FEMALE; HEMATOLOGIC MALIGNANCY; HLA MATCHING; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PLASMACYTOID DENDRITIC CELL; PROGNOSIS; RISK FACTOR;

ADOLESCENT; ADULT; AGE FACTORS; BLOOD CELL COUNT; CELL COUNT; CHILD; CHILD, PRESCHOOL; DENDRITIC CELLS; DISEASE-FREE SURVIVAL; FEMALE; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEUTROPHILS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PLATELET COUNT; RECURRENCE; RISK FACTORS; SURVIVAL ANALYSIS; T-LYMPHOCYTES, HELPER-INDUCER; TRANSPLANTATION CHIMERA; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TRANSPLANTS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77952571250     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2010.01.013     Document Type: Article

References (25)

1. Korbling M. Peripheral blood stem cells: a novel source for allogeneic transplantation. Oncologist 1997, 2:104-113.
2. Korbling M., Anderlini P. Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter?. Blood 2001, 98:2900-2908.
3. Schmitz N., Barrett J. Optimizing engraftment-source and dose of stem cells. Semin Hematol 2002, 39:3-14.
4. Savani B.N., Mielke S., Rezvani K., et al. Absolute lymphocyte count on day 30 is a surrogate for robust hematopoietic recovery and strongly predicts outcome after T cell-depleted allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2007, 13:1216-1223.
5. Berger M., Figari O., Bruno B., et al. Lymphocyte subsets recovery following allogeneic bone marrow transplantation (BMT): CD4+ cell count and transplant-related mortality. Bone Marrow Transplant 2008, 41:55-62.
6. MacDonald K.P., Munster D.J., Clark G.J., Dzionek A., Schmitz J., Hart D.N. Characterization of human blood dendritic cell subsets. Blood 2002, 100:4512-4520.
7. Waller E.K., Rosenthal H., Sagar L. DC2 effect on survival following allogeneic bone marrow transplantation. Oncology (Williston Park) 2002, 16:19-26.
8. Fagnoni F.F., Oliviero B., Giorgiani G., et al. Reconstitution dynamics of plasmacytoid and myeloid dendritic cell precursors after allogeneic myeloablative hematopoietic stem cell transplantation. Blood 2004, 104:281-289.
9. Arpinati M., Green C.L., Heimfeld S., Heuser J.E., Anasetti C. Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells. Blood 2000, 95:2484-2490.
10. Arpinati M., Chirumbolo G., Urbini B., Perrone G., Rondelli D., Anasetti C. Role of plasmacytoid dendritic cells in immunity and tolerance after allogeneic hematopoietic stem cell transplantation. Transpl Immunol 2003, 11:345-356.
11. Reddy V., Iturraspe J.A., Tzolas A.C., Meier-Kriesche H.U., Schold J., Wingard J.R. Low dendritic cell count after allogeneic hematopoietic stem cell transplantation predicts relapse, death, and acute graft-versus-host disease. Blood 2004, 103:4330-4335.
12. Rajasekar R., Mathews V., Lakshmi K.M., et al. Plasmacytoid dendritic cell count on day 28 in HLA-matched related allogeneic peripheral blood stem cell transplant predicts the incidence of acute and chronic GVHD. Biol Blood Marrow Transplant 2008, 14:344-350.
13. Waller E.K., Li J.M. Donor dendritic cells dance the do-si-do in allogeneic transplantation. Blood 2008, 112:3007-3008.
14. Waller E.K., Rosenthal H., Jones T.W., et al. Larger numbers of CD4(bright) dendritic cells in donor bone marrow are associated with increased relapse after allogeneic bone marrow transplantation. Blood 2001, 97:2948-2956.
15. Taylor P.A., Ehrhardt M.J., Lees C.J., et al. TLR agonists regulate alloresponses and uncover a critical role for donor APCs in allogeneic bone marrow rejection. Blood 2008, 112:3508-3516.
16. Sutherland D.R., Anderson L., Keeney M., Nayar R., Chin-Yee I. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother 1996, 5:213-226.
17. Vakkila J., Thomson A.W., Hovi L., Vettenranta K., Saarinen-Pihkala U.M. Circulating dendritic cell subset levels after allogeneic stem cell transplantation in children correlate with time post transplant and severity of acute graft-versus-host disease. Bone Marrow Transplant 2005, 35:501-507.
18. Young J.W., Merad M., Hart D.N. Dendritic cells in transplantation and immune-based therapies. Biol Blood Marrow Transplant 2007, 13:23-32.
19. Merad M., Collin M., Bromberg J. Dendritic cell homeostasis and trafficking in transplantation. Trends Immunol 2007, 28:353-359.
20. Rossi M., Arpinati M., Rondelli D., Anasetti C. Plasmacytoid dendritic cells: do they have a role in immune responses after hematopoietic cell transplantation?. Hum Immunol 2002, 63:1194-1200.
21. Steinman R.M., Turley S., Mellman I., Inaba K. The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med 2000, 191:411-416.
22. Lonial S., Torre C., David E., Harris W., Arellano M., Waller E.K. Regulation of alloimmune responses by dendritic cell subsets. Exp Hematol 2008, 36:1309-1317.
23. Jordan C.T., Upchurch D., Szilvassy S.J., et al. The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells. Leukemia 2000, 14:1777-1784.
24. Du X., Ho M., Pastan I. New immunotoxins targeting CD123, a stem cell antigen on acute myeloid leukemia cells. J Immunother 2007, 30:607-613.
25. Lock R.B.L.L., Lee L.M. CD123 neutralization antibody selectively eliminates human acute myeloid leukemic stem cells. Blood 2007, 110:161.